The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Seattle Genetics Inc

Nasdaq: SGEN
Last

(U.S.) $59.27

Today's change+0.23 +0.39%
Updated January 19 4:00 PM EST. Delayed by at least 15 minutes.
 

Seattle Genetics Inc

Nasdaq: SGEN
Last

(U.S.) $59.27

Today's change+0.23 +0.39%
Updated January 19 4:00 PM EST. Delayed by at least 15 minutes.

Seattle Genetics Inc up (U.S.)$0.23

Seattle Genetics Inc closed up Thursday by (U.S.)$0.23 or 0.39% to (U.S.)$59.27. Over the last five days, shares have gained 0.70% and outperformed the S&P 500 index over the last 52 weeks with a 67.48% increase in price.

Key company metrics

  • Open(U.S.) $59.31
  • Previous close(U.S.) $59.04
  • High(U.S.) $59.41
  • Low(U.S.) $58.20
  • Bid / Ask(U.S.) $53.14 / (U.S.) $59.51
  • YTD % change+12.32%
  • Volume874,886
  • Average volume (10-day)1,419,115
  • Average volume (1-month)1,316,893
  • Average volume (3-month)1,261,578
  • 52-week range(U.S.) $26.02 to (U.S.) $75.36
  • Beta2.24
  • Trailing P/ENegative, not meaningful
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) -$0.78
Updated January 19 4:00 PM EST. Delayed by at least 15 minutes.
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2016Q2/2016Q1/2016Q4/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedSep 30, 201609/30/2016Jun 30, 201606/30/2016Mar 31, 201603/31/2016Dec 31, 201512/31/2015
Revenue1069511193
Total other revenue--------
Total revenue1069511193
Gross profit958510283
Total cost of revenue11101010
Total operating expense139129132119
Selling / general / administrative35333034
Research & development93869375
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total--------
Operating income-32-33-21-25
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax-32-33-20-25
Income after tax-32-33-20-25
Income tax, total--------
Net income-32-33-20-25
Total adjustments to net income--------
Net income before extra. items-32-33-20-25
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-32-33-20-25
Inc. avail. to common incl. extra. items-32-33-20-25
Diluted net income-32-33-20-25
Dilution adjustment--------
Diluted weighted average shares141140140140
Diluted EPS excluding extraordinary itemsvalue per share-0.23-0.23-0.15-0.18
Dividends per sharevalue per share0.000.000.000.00
Diluted normalized EPSvalue per share-0.23-0.23-0.15-0.18